Peregrine Capital Management’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-135,678	Closed	-$4.91M	–	338
2024 Q4	$4.91M	Sell	135,678 -63,974	-32%	-$2.31M	0.15%	226
2024 Q3	$6.23M	Sell	199,652 -2,642	-1%	-$82.4K	0.19%	163
2024 Q2	$5.41M	Sell	202,294 -699	-0.3%	-$18.7K	0.16%	220
2024 Q1	$6.92M	Buy	+202,993	New	+$6.92M	0.2%	174